Peter Fong
CIK: 0002062181
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RCKT
ROCKET PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
About Fong Peter
Fong Peter (SEC CIK 0002062181) files insider reports with the SEC as Director of ROCKET PHARMACEUTICALS, INC. (RCKT).
Signal8 holds 3 ownership filings by Fong Peter (1 Form 3, 2 Form 4), filed between Oct 3, 2025 and Jul 6, 2026. Those filings report 3 transactions, from Sep 24, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fong Peter's filings is in CRANBURY, NJ.
Recent filings by Fong Peter
Other insiders filing for ROCKET PHARMACEUTICALS, INC. (RCKT)
- Wilson Martin, General Counsel
- Shah Gaurav, CEO
- Stevens Christopher James, Chief Operating Officer
- Chaudhuri Sarbani
- SOUTHWELL DAVID P, Director
- Manhede Joseph, Principal Accounting Officer